Bicara Therapeutics BCAX Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's common stock shares issued?
- Bicara Therapeutics (BCAX) reported common stock shares issued of 65.5M in Q1 2026.
- How has Bicara Therapeutics's common stock shares issued changed year-over-year?
- Bicara Therapeutics's common stock shares issued increased by 20.2% year-over-year, from 54.5M to 65.5M.
- What is the long-term trend for Bicara Therapeutics's common stock shares issued?
- Over 2 years (2023 to 2025), Bicara Therapeutics's common stock shares issued has grown at a 791.7% compound annual growth rate (CAGR), from 711.9K to 56.6M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.